Accelerated hypofractionated radiotherapy in men with localized prostate cancer: long-term outcomes

被引：0
作者：
Galalae, R
Schultze, J
Nuernberg, N
Kohr, P
机构：
[1] Univ Hosp Schleswig Holstein, Kiel, Germany
[2] Municipal Hosp, Kiel, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [31] Long-term outcomes of hypofractionated radiation therapy in patients with high risk prostate cancer
    Bulychkin, P. V.
    Ekaterinushkin, D. A.
    Tkachev, S. I.
    Khachaturyan, A. V.
    Nayanov, G. B.
    Ladyko, D. D.
    Selezneva, T. D.
    ONKOUROLOGIYA, 2024, 20 (01): : 60 - 66
  • [32] Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes
    Faria, Sergio L.
    Neto, Osmar B.
    Cury, Fabio
    Shenouda, George
    Russel, Ruo
    Souhami, Luis
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (02) : 8209 - 8214
  • [33] Hypofractionated intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcome results
    Thakkar, VV
    Khuntia, D
    Reddy, CA
    Mahadevan, EA
    Klein, A
    Chehade, N
    Kupelian, PA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S124 - S125
  • [34] Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
    Koukourakis, Ioannis M.
    Panteliadou, Marianthi
    Giakzidis, Axiotis G.
    Nanos, Christos
    Abatzoglou, Ioannis
    Giatromanolaki, Alexandra
    Koukourakis, Michael I.
    CURRENT ONCOLOGY, 2021, 28 (05) : 3474 - 3487
  • [35] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Morgan, Scott C.
    Holmes, Oliver E.
    Craig, Julia
    Grimes, Scott
    Malone, Shawn
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1041 - 1047
  • [36] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Scott C. Morgan
    Oliver E. Holmes
    Julia Craig
    Scott Grimes
    Shawn Malone
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 1041 - 1047
  • [37] Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
    Teh, Bin S.
    Lewis, Gary D.
    Mai, Weiyuan
    Pino, Ramiro
    Ishiyama, Hiromichi
    Butler, Edward Brian
    CANCER COMMUNICATIONS, 2018, 38
  • [38] Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).
    Mian, Omar Y.
    Abu-Gheida, Ibrahim
    Kotecha, Rupesh
    Weller, Michael A.
    Reddy, Chandana A.
    Kupelian, Patrick
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Stephenson, Andrew J.
    Klein, Eric A.
    Shah, Chirag
    Ciezki, Jay P.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [39] Long-Term Outcomes Of Hypofractionated Stereotactic Radiotherapy For Treatment Of Arteriovenous Malformation
    Glazener, E. M.
    Chen, J. C. T.
    Lodin, K.
    Miller, M. J.
    Rahimian, J.
    Frager, M. J.
    Girvigian, M. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E726 - E726
  • [40] Long-term Quality of Life after Prostatectomy and percutaneous Radiotherapy for localized Prostate Cancer
    Simeonova, A.
    Wenz, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (09) : 804 - 805
12345